
personalized-medicine


Helsinki-based health technology firm CurifyLabs has closed a $14 million Series A round to grow its automated system for producing personalized medications. The round was co-led by Sandwater and HealthCap, with Tesi and existing backers including Lifeline Ventures joining, alongside participation from U.S. customers and employees. The company, which also operates out of Jacksonville, Florida,…

For patients with Stage IV cancers of the colorectum or appendix that have spread to the abdominal lining, early intervention is key. Without it, many patients face a life expectancy of just one year and significantly reduced quality of life.
Pulse 2.0 interviewed MTM alumnus Sungwon Lim, founder of ImpriMed, a company that provides personalized medicine for pets with blood cancer diseases.
After losing three grandparents to cancer and taking a close look at intestinal diseases, Postdoctoral Fellow Alican Ozkan is determined to find better therapeutic options for all patients, regardless of race, ethnicity, age, or sex
From considering the potential applications of personalised medicine to evaluating the ethical concerns that may come alongside it, this paper delves into the cutting edge of research in the medical technology field.
Maria Marti Solano focuses on proteins that are relevant for the effect of medicines with a computational approach. Der Beitrag Young Scientists at #LINO70: Maria Marti Solano – On the Way to a More Personalised Medicine erschien zuerst auf Lindau Nobel Laureate Meetings .
The Rise of Individualized Cancer Treatments There is so much diversity in the human race. No two people are exactly alike; even identical twins have different finger prints. We all have different physical appearances, personal preferences and unfortunately, responses to diseases. This makes finding a cure to any disease remarkably difficult; let alone cancer, which The post The Rise of Individua…


